Current Surgical raises $9.5M for AI-powered cancer treatment platform
Current Surgical has closed an oversubscribed $9.5 million Seed+ funding round, investor Wavemaker Three-Sixty Health announced in a LinkedIn post.1
By Victoria Shi · AI Funding Reporter Nov 20, 2026

Wavemaker Three-Sixty Health participated in the round. The company is developing a platform that combines robotics, AI, and focused ultrasound for precision cancer treatment, according to the post. The funding will help the company advance toward first-in-human studies, Wavemaker Three-Sixty Health said.
According to press releases from a prior funding round, Current Surgical is developing a software-enabled surgical platform with a smart surgical needle. The technology aims to allow doctors to precisely destroy solid tumors without harming nearby healthy tissue.3
The Washington, D.C.-based company was founded in 2020 by Alireza (Al) Mashal and Chris Wagner, PR Newswire reported. In February 2023, Current Surgical announced a $3.2 million seed round led by True Ventures, with participation from 1517 Fund and SciFounders.2,3